Quercetin potentiates the chemosensitivity of MCF-7 breast cancer cells to 5-fluorouracil
- PMID: 34637097
- DOI: 10.1007/s11033-021-06782-3
Quercetin potentiates the chemosensitivity of MCF-7 breast cancer cells to 5-fluorouracil
Abstract
Background: Breast cancer is one of the leading causes of cancer mortality worldwide. 5-fluorouracil (5-FU) is one of the chemotherapy drugs to treat breast cancer, but it is associated with several side effects. Combination therapy is a way to increase the effectiveness of chemo drugs and decrease their usage dose. Quercetin (Quer) is one of the natural polyphenols with anti-cancer properties. This study investigated the apoptotic effect of 5-FU in combination with Quer compared with 5-FU alone on MCF-7 breast cancer cells.
Method and results: Different single and combined concentrations of 5-FU and Quer were applied to MCF 7 cells for 48 h. Cell viability, apoptosis, gene expression of Bax, Bcl2, and p53, caspase activity, and colony number were assessed using MTT assay, flow cytometry, quantitative real-time PCR, enzyme-linked immunosorbent (ELISA), and Colony formation assay, respectively. The combination of 5-FU and Quer compared to 5-FU alone improved apoptosis by increasing the gene expression of Bax and p53 and caspase-9 activity and decreasing the Bcl2 gene expression. Colony formation in MCF-7 cells significantly decreased in the combined state compared to 5-FU alone.
Conclusion: Quer potentiates the sensitivity of breast cancer to 5-FU so that this combination may be proposed as a treatment for breast cancer. Therefore, this combination can be suggested for future in vivo studies.
Keywords: 5-Fluorouracil; Breast cancer; Chemosensitivity; Potentiate; Quercetin.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.Biomed Pharmacother. 2019 Jun;114:108855. doi: 10.1016/j.biopha.2019.108855. Epub 2019 Apr 16. Biomed Pharmacother. 2019. PMID: 31003140
-
Cadmium modifies the cell cycle and apoptotic profiles of human breast cancer cells treated with 5-fluorouracil.Int J Mol Sci. 2013 Aug 12;14(8):16600-16. doi: 10.3390/ijms140816600. Int J Mol Sci. 2013. PMID: 23941782 Free PMC article.
-
Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.PLoS One. 2018 Apr 4;13(4):e0192888. doi: 10.1371/journal.pone.0192888. eCollection 2018. PLoS One. 2018. PMID: 29617363 Free PMC article.
-
The Effects of Quercetin on the Apoptosis of Human Breast Cancer Cell Lines MCF-7 and MDA-MB-231: A Systematic Review.Nutr Cancer. 2022;74(2):405-422. doi: 10.1080/01635581.2021.1897631. Epub 2021 Mar 7. Nutr Cancer. 2022. PMID: 33682528
-
Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy.Cell Commun Signal. 2023 Feb 9;21(1):33. doi: 10.1186/s12964-023-01047-x. Cell Commun Signal. 2023. PMID: 36759799 Free PMC article. Review.
Cited by
-
Quercetin: A Natural Ally in Combating Breast Cancer.Int J Nanomedicine. 2025 Jul 19;20:9155-9177. doi: 10.2147/IJN.S518174. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40708864 Free PMC article. Review.
-
Quercetin-loaded solid lipid nanoparticles exhibit antitumor activity and suppress the proliferation of triple-negative MDA-MB 231 breast cancer cells: implications for invasive breast cancer treatment.Mol Biol Rep. 2023 Nov;50(11):9417-9430. doi: 10.1007/s11033-023-08848-w. Epub 2023 Oct 13. Mol Biol Rep. 2023. PMID: 37831347
-
Quercetin potentiates 5-fluorouracil effects in human colon cancer cells through targeting the Wnt/β-catenin signalling pathway: the role of miR-27a.Contemp Oncol (Pozn). 2022;26(3):229-238. doi: 10.5114/wo.2022.120361. Epub 2022 Oct 24. Contemp Oncol (Pozn). 2022. PMID: 36381675 Free PMC article.
-
From nature to clinic: Quercetin's role in breast cancer immunomodulation.Front Immunol. 2024 Dec 6;15:1483459. doi: 10.3389/fimmu.2024.1483459. eCollection 2024. Front Immunol. 2024. PMID: 39712006 Free PMC article. Review.
-
Synergistic chemotherapy and immunomodulatory effects of Quercetin in cancer: a review.Front Immunol. 2025 May 26;16:1547992. doi: 10.3389/fimmu.2025.1547992. eCollection 2025. Front Immunol. 2025. PMID: 40491926 Free PMC article. Review.
References
-
- Elmadany N, Khalil E, Vaccari L, Birarda G, Yousef I, Abu-Dahab R (2018) Antiproliferative activity of the combination of doxorubicin/quercetin on MCF7 breast cancer cell line: a combined study using colorimetric assay and synchrotron infrared microspectroscopy. Infrared Phys Technol 95:141–147
-
- Kawabata R, Oie S, Takahashi M, Kanayama H, Oka T, Itoh K (2011) Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell lines. Int J Oncol 38:1489–1500 - PubMed
-
- Zhang D, Liu X, Gao J et al (2017) The role of epithelial cell adhesion molecule N-glycosylation on apoptosis in breast cancer cells. Tumor Biol 39:1010428317695973
-
- Ponce-Cusi R, Calaf GM (2016) Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation. Int J Oncol 48:774–782 - PubMed
-
- Castillo RR, Colilla M, Vallet-Regí M (2017) Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer. Expert Opin Drug Deliv 14:229–243 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous